Patents

US 10925845 B2: Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB)

Granted
2021-02-23
Filed
2019-06-25 application 16451516
Type
Utility · 13 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention provides a composition comprising an acidic formulation containing β-hydroxy-β-methylbutyrate (HMB), preferably in the free acid form, Vitamin D and a stabilizing excipient, wherein the Vitamin D is stabilized against degradation.

Source: PVGPATDIS, file of 2026-04-10 (ipg210223.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Metabolic Technologies, LLC 20 patentsUS company or organizationAmes, IAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
John RathmacherStory City, IA22PVGPATDIS, file of 2026-04-10
Martin PurpuraAustin, TX8PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/191PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-01-20Assignment
Assignment of assignor's interest
PURPURA, MARTIN signed 2020-10-21
RATHMACHER, JOHN signed 2020-10-22
METABOLIC TECHNOLOGIES, INC. AMES, IA54963/186ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.